NSNevine F. Shafik
Nevine F. Shafik
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nevine F. Shafik has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Rasha Mahmoud Allam
Cancer Epidemiology & Biostatistics Department, National Cancer Institute, Cairo University, Egypt
2 shared publicationsAmal Fawzy
Clinical Pathology and Oncologic Laboratory Medicine Department, National Cancer Institute, Cairo University, Egypt
1 shared publicationAmany Helal
Medical Oncology Department, National Cancer Institute, Cairo University, Egypt
1 shared publicationAmira D. Darwish
Medical Oncology Department, National Cancer Institute, Cairo University, Egypt
1 shared publicationDalia Negm Eldin
Department of Biostatistics and Cancer Epidemiology, National Cancer Institute, Cairo University, Egypt
1 shared publicationEman Z. Kandeel
Clinical pathology, National Cancer Institute, Cairo University, Egypt
1 shared publication
Latest Publications
- 1 December 2021
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 123, 104718
Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients
- 1 December 2021
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 123, 104718
Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients
- 1 October 2021
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21 (10) , 676-685
FLT3-ITD Allele Frequency Is an Independent Prognostic Factor for Poor Outcome in FLT3-ITD–Positive AML Patients
- 1 October 2021
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21 (10) , 676-685
FLT3-ITD Allele Frequency Is an Independent Prognostic Factor for Poor Outcome in FLT3-ITD–Positive AML Patients
- 1 February 2021
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 118, 104597
Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia
- 1 February 2021
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 118, 104597
Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia